Global Colon Cancer Association, shared a post on LinkedIn:
“Clinical trials can only improve outcomes for all patients when they reflect the communities they are intended to serve.
On July 23, GCCA CEO Andrew Spiegel, Esq. Spiegel will join senior leaders from Takeda Oncology, Kite Pharma, and Johnson & Johnson at a Reuters Events webinar to discuss practical strategies for improving clinical trial representation, reducing barriers to participation, and building stronger partnerships with patient advocacy organizations and community leaders.
The discussion will explore how sponsors and researchers can:
- Identify diverse patient populations earlier in trial design
- Make smarter site selection decisions
- Build trust through community partnerships
- Improve recruitment while enhancing representation
- July 23, 2026
- 11:00 AM EDT
Can’t attend live? Register to receive the recording.”
